Screening (TB)

Rapid Culture Confirmation Test for TB Developed

Published in TB and Outbreaks Week, February 3rd, 1997

ID Biomedical Corp. (IDB), Vancouver, British Columbia, announced that it has been developing a rapid culture confirmation test for tuberculosis (TB) in collaboration with Dr. Kathy Eisenach, University of Arkansas.

The TB test uses IDB's proprietary DNA-based diagnostic system, Cycling Probe Technology (CPT). IDB has also been developing CPT-based culture confirmation tests for two antibiotic resistant bacteria, MRSA and VRE. The TB test uses the same commercial format that has been developed by IDB for the MRSA and VRE tests.

IDB and Dr. Eisenach recently demonstrated the feasibility of detecting the TB organism using IDB's CPT technology with a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-02-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry